Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Johnson
Dale N Gerding

Showing results (161-170 of 283) with videos related to

Pageof 29
Sort By:
Plos One|November 23, 2013
Surface-layer protein A (SlpA) is a major contributor to host-cell adherence of Clostridium difficileMichelle M Merrigan, Anilrudh Venugopal, Jennifer L Roxas, et al.
Anaerobe|July 26, 2011
Introduction to the special issue highlighting Anaerobe 2010David M Aronoff, Stuart Johnson, Bennett Lorber
Annals of Internal Medicine|July 18, 2002
Hepatotoxicity after prophylaxis with a nevirapine-containing antiretroviral regimenStuart Johnson, Juliana Chan, Charles L Bennett
Chemical Communications (Cambridge, England)|February 20, 2020
Arylation and alkenylation of activated alkyl halides using sulfonamidesStuart Johnson, Ervin Kovács, Michael F Greaney
Infection Control and Hospital Epidemiology|November 28, 2002
Difference in the incidence of Clostridium difficile among patients infected with human immunodeficiency virus admitted to a public hospital and a private hospitalJoseph J Pulvirenti, Dale N Gerding, Catherine Nathan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2019
Effect of Endogenous Clostridioides difficile Toxin Antibodies on Recurrence of C. difficile InfectionCiarán P Kelly, Ian R Poxton, Judong Shen, et al.
Vaccine|November 28, 2009
Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)Brett A Leav, Barbra Blair, Mark Leney, et al.
Emerging Infectious Diseases|April 23, 2010
Multihospital outbreak of Clostridium difficile infection, Cleveland, Ohio, USARobin L P Jump, Michelle M Riggs, Ajay K Sethi, et al.
Infection Control and Hospital Epidemiology|January 25, 2024
Potential underreporting of treated patients using a <i>Clostridioides difficile</i> testing algorithm that screens with a nucleic acid amplification testAlice Y Guh, Scott Fridkin, Dana Goodenough, et al.
Diagnostic Microbiology and Infectious Disease|January 25, 2003
Epidemiology and outcome of Clostridium difficile infection and diarrhea in HIV infected inpatientsJoseph J Pulvirenti, Tarun Mehra, Irfan Hafiz, et al.
Pageof 29

Showing results (161-170 of 283) with videos related to

Sort By:
Pageof 29
Plos One|November 23, 2013
Surface-layer protein A (SlpA) is a major contributor to host-cell adherence of Clostridium difficileMichelle M Merrigan, Anilrudh Venugopal, Jennifer L Roxas, et al.
Anaerobe|July 26, 2011
Introduction to the special issue highlighting Anaerobe 2010David M Aronoff, Stuart Johnson, Bennett Lorber
Annals of Internal Medicine|July 18, 2002
Hepatotoxicity after prophylaxis with a nevirapine-containing antiretroviral regimenStuart Johnson, Juliana Chan, Charles L Bennett
Chemical Communications (Cambridge, England)|February 20, 2020
Arylation and alkenylation of activated alkyl halides using sulfonamidesStuart Johnson, Ervin Kovács, Michael F Greaney
Infection Control and Hospital Epidemiology|November 28, 2002
Difference in the incidence of Clostridium difficile among patients infected with human immunodeficiency virus admitted to a public hospital and a private hospitalJoseph J Pulvirenti, Dale N Gerding, Catherine Nathan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2019
Effect of Endogenous Clostridioides difficile Toxin Antibodies on Recurrence of C. difficile InfectionCiarán P Kelly, Ian R Poxton, Judong Shen, et al.
Vaccine|November 28, 2009
Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)Brett A Leav, Barbra Blair, Mark Leney, et al.
Emerging Infectious Diseases|April 23, 2010
Multihospital outbreak of Clostridium difficile infection, Cleveland, Ohio, USARobin L P Jump, Michelle M Riggs, Ajay K Sethi, et al.
Infection Control and Hospital Epidemiology|January 25, 2024
Potential underreporting of treated patients using a <i>Clostridioides difficile</i> testing algorithm that screens with a nucleic acid amplification testAlice Y Guh, Scott Fridkin, Dana Goodenough, et al.
Diagnostic Microbiology and Infectious Disease|January 25, 2003
Epidemiology and outcome of Clostridium difficile infection and diarrhea in HIV infected inpatientsJoseph J Pulvirenti, Tarun Mehra, Irfan Hafiz, et al.
Pageof 29